Literature DB >> 28328354

Harms of Deception in FMR1 Premutation Genotype-Driven Recruitment.

Sam Doernberg1, Sara Chandros Hull2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28328354      PMCID： PMC6097709          DOI： 10.1080/15265161.2017.1284920

Source DB:  PubMed          Journal:  Am J Bioeth        ISSN： 1526-5161            Impact factor:   11.229


× No keyword cloud information.
  7 in total

1.  Recommendations for ethical approaches to genotype-driven research recruitment.

Authors:  Laura M Beskow; Stephanie M Fullerton; Emily E Namey; Daniel K Nelson; Arlene M Davis; Benjamin S Wilfond
Journal:  Hum Genet       Date:  2012-05-24       Impact factor: 4.132

2.  Women's attitudes toward testing for fragile X carrier status: a qualitative analysis.

Authors:  Aimee Anido; Lisa M Carlson; Lisa Taft; Stephanie L Sherman
Journal:  J Genet Couns       Date:  2005-08       Impact factor: 2.537

3.  "It's about having the choice": stakeholder perceptions of population-based genetic carrier screening for fragile X syndrome.

Authors:  Alison D Archibald; Chriselle L Hickerton; Alice M Jaques; Samantha Wake; Jonathan Cohen; Sylvia A Metcalfe
Journal:  Am J Med Genet A       Date:  2012-12-13       Impact factor: 2.802

4.  Attitudes towards potentially carrying the FMR1 premutation: before vs after testing of non-carrier females with diminished ovarian reserve.

Authors:  Lisa M Pastore; Maria Antero; Karen Ventura; J Kim Penberthy; Semara A Thomas; Logan B Karns
Journal:  J Genet Couns       Date:  2014-05-03       Impact factor: 2.537

5.  Longitudinal study of the carrier testing process for fragile X syndrome: perceptions and coping.

Authors:  A McConkie-Rosell; G A Spiridigliozzi; J A Sullivan; D V Dawson; A M Lachiewicz
Journal:  Am J Med Genet       Date:  2001-01-01

6.  Do researchers have an obligation to actively look for genetic incidental findings?

Authors:  Catherine Gliwa; Benjamin E Berkman
Journal:  Am J Bioeth       Date:  2013       Impact factor: 11.229

7.  FMR1 premutation carrier frequency in patients undergoing routine population-based carrier screening: insights into the prevalence of fragile X syndrome, fragile X-associated tremor/ataxia syndrome, and fragile X-associated primary ovarian insufficiency in the United States.

Authors:  Feras M Hantash; Dana M Goos; Beryl Crossley; Ben Anderson; Ke Zhang; Weimin Sun; Charles M Strom
Journal:  Genet Med       Date:  2011-01       Impact factor: 8.822
  7 in total
  2 in total

Review 1.  Ethical, legal and social/societal implications (ELSI) of recall-by-genotype (RbG) and genotype-driven-research (GDR) approaches: a scoping review.

Authors:  Katharina Tschigg; Luca Consoli; Roberta Biasiotto; Deborah Mascalzoni
Journal:  Eur J Hum Genet       Date:  2022-06-15       Impact factor: 5.351

2.  Balancing scientific interests and the rights of participants in designing a recall by genotype study.

Authors:  Deborah Mascalzoni; Roberta Biasiotto; Max Borsche; Norbert Brüggemann; Alessandro De Grandi; Martin Goegele; Sara Frygner-Holm; Christine Klein; Maria Kösters; Ciara Staunton; Peter P Pramstaller; Michael Krawczak; Andrew A Hicks
Journal:  Eur J Hum Genet       Date:  2021-05-13       Impact factor: 4.246
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.